Overview Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects Status: Recruiting Trial end date: 2022-05-31 Target enrollment: Participant gender: Summary The purpose of this study was to investigate Safety, tolerability and pharmacokinetics in Chinese healthy subjects. Phase: Phase 1 Details Lead Sponsor: Newsoara Biopharma Co., Ltd.